39 新規抗癌抗生物質Duocarmycin類の構造(口頭発表の部)
スポンサーリンク
概要
- 論文の詳細を見る
Duocarmycin A, C_1 and C_2 produced by Streptomyces sp. are novel antitumor antibiotics which are effective against murine lymphocytic leukemia p388 and murine Sarcoma 180 in mice. In this report, we describe the structural determination of the Duocarmycins (Fig. 1). The ^1H NMR spectrum of Duocarmycin C_1 (1) revealed the presence of three aromatic protons, four methoxyl groups, one tert. methyl group, two methylene groups, one methine proton and three protons which disappeared in the presence of D_2O (Table 2). The observation of ^1H-^<13>C long range couplings through COLOC spectrum of 1 exhibited three partial structures (I, II and III) shown in Fig. 2. The attachment of the amino group between C-2 and C-9a, and of the phenolic OH group to C-9 were also established by COLOC experiment of a permethylate 4, where the long range couplings from N-methyl and O-methyl protons were observed (Fig. 3). Treatment of 1 with triethylamine in methanol at room temperature in the presence of Ag_2CO_3 produced a quinoline derivative 6, indicating the presence of nitrogen linked to C-6 and C-7a. The attachment of the chlorine to C-5 was confirmed by alkaline treatment of 4 producing a dehydrochloride 5. The partial structure III was defined by isolation of the alkaline degradation product 7. The observation of NOE between 1-NH and 9-OH confirmed the attachment of N-1 to C-9a and C-3 to C-3a in the partial structure I and II. The long range couplings between 6-H_2 and C-2'α determined by LSPD experiment established the connection of C-2'α to N-7, thus confirming the whole structure of 1 as shown in Fig. 1. The structure of Duocarmycin C_2 (2) is different from that of 1 with respect to the chlorine-containing moiety. The ^1H NMR spectrum showed that chloromethyl protons were coupled to a methine, which in tern was coupled to a nitrogen-bearing methylene. This indicated that 2 had a dihydroindole skeleton on the corresponding partial structure II of 1. The structural differences between Duocarmycin A (3) and Duocarmycin C_1 are also related to the partial structure II. The COLOC spectrum revealed the structure of 3 having dienone conjugated with the cyclopropane ring (Fig. 4). Treatment of 3 with hydrochloric acid in acetone gave 1 and 2 in the ratio ca. 1:4 (Fig. 5). This provided the evidence for the structures of Duocarmycins and meant that 1 and 2 seemed to be artifact products of 3.
- 天然有機化合物討論会の論文
- 1988-09-26
著者
-
佐野 浩
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
佐野 浩
協和発酵東京研
-
高橋 恵一
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Sano H
Institute Of Molecular & Cellular Biosciences The University Of Tokyo
-
安澤 亨
協和発酵東京研
-
飯田 孝男
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
飯田 孝男
協和発酵東京研
-
高橋 勇美
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
高橋 勇
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
市村 通朗
協和発酵医薬研
-
室井 健一
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
小川 達洋
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
高橋 勇
協和発酵東京研
-
室井 健一
協和発酵医薬研
-
小川 達洋
協和発酵医薬研
-
高橋 恵一
協和発酵医薬研
-
安澤 亨
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd. :(present Address)pharmaceutical Research Lab
-
室井 健一
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Muroi K
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
小川 達洋
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Takahashi K
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Ichimura M
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
関連論文
- 243 ソルビン酸含有ワイン中に生ずる不快臭原因物質の単離・精製および同定
- 91 新規テトラテルペノイドKS-505の構造決定(口頭発表の部)
- 9 カルモジュリン依存性ホスホジエステラーゼ阻害物質KS-501およびKS-502の構造決定(ポスター発表の部)
- Studies on the Syntheses of Heterocyclic Compounds. DX. A Novel Rearrangement of proerythrinadienol with Methyl Fluorosulfonate
- Studies on the Syntheses of Heterocyclic Compounds. CDLXXXVII. Photolytic Synthesis and Rearrangement of Proerythrinadienones
- Biotransformation of (+)-Reticuline in Rat
- 新抗腫瘍性抗生物質DC89-A1(有機化学・天然物化学-抗生物質生理活性物質(微生物)-)
- 新規Pyrrolo(1,4)benzodiazepine系抗癌抗生物質DC102 : 単離, 構造と生物活性(有機化学・天然物化学-抗生物質-)
- 放線菌Catellatospora ferrugineaに存在する未知糖の単離と同定(微生物-生態, 分類-)
- 26 抗腫瘍性抗生物質,トリオキサカルシンの構造
- 362 Micromonospora sagamiensis変異株によるSU-2 関連物質の蓄積機構と2-デオキシストレプタミン生合成
- 74 アンスラ-γ-ピロン型抗腫瘍性抗生物質の構造決定(ポスター発表の部)
- 77(PB2-7) 糸状菌Penicillium paxilliの生産する新規ステロールUCY-1003の構造決定(ポスター発表の部)
- N-Phenylphthalimide-Type Cyclooxygenase (COX) Inhibitors Derived from Thalidomide : Substituent Effects on Subtype Selectivity
- Thalidomide as a Nitric Oxide Synthase Inhibitor and Its Structural Development
- Calmodulin-dependent Cyclic Nucleotide Phosphodiesterase(PDEI)Isoform選択的阻害剤KS-505a
- Duocarmycins, Potent Antitumor Antibiotics Produced by Streptomyces sp. Structures and Chemistry
- 39 新規抗癌抗生物質Duocarmycin類の構造(口頭発表の部)
- STRUCTURES OF DUOCARMYCINS, NOVEL ANTITUMOR ANTIBIOTICS PRODUCED BY STREPTOMYCES SP.
- 新抗腫瘍性抗生物質DC92-B
- 81(P2-11) カルモジュリン依存性ホスホジエステラーゼ阻害物質KS-506類の構造決定(ポスター発表の部)
- 361 Micromonospora sagamiensisのBlocked Mutantを用いた新規アミノグリコシド抗生物質の生産
- 208 Micromonospora sagamiensis変異株による抗生物質G-52の生産
- 207 Micromonospora sagamiensisによるベルダミシン, シソミシンからジェンタミシン, サガミシンの生成
- Identification of a Novel Aminonucleoside Produced by Enterobacter sp. as 2'-Amino-2'-deoxyguanosine